Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hepatitis

Free Subscription 01.04.2024 1 BMC Gastroenterol 1 Clin Infect Dis 5 J Hepatol 1 J Infect Dis 1 J Med Virol 1 J Viral Hepat 1 J Virol 1 PLoS Comput Biol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. WEI S, Xie Q, Liao G, Chen H, et al
   Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.
   BMC Gastroenterol. 2024;24:120.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
   Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
   Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Hepatol

3. HIN-MAN LEUNG R, Wan-Hin Hui R, Mak LY, Mao X, et al
   ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B.
   J Hepatol. 2024 Mar 23:S0168-8278(24)00204-6. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
4. PASTA A, Pieri G, Plaz Torres MC, Trevisani F, et al
   Hepatocellular carcinoma in patients with Autoimmune Hepatitis.
   J Hepatol. 2024 Mar 23:S0168-8278(24)00208-3. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   
5. PLAGIANNAKOS CG, Hirschfield GM, Lytvyak E, Roberts SB, et al
   Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study.
   J Hepatol. 2024 Mar 23:S0168-8278(24)00205-8. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
6. SEMMLER G, Alonso Lopez S, Pons M, Lens S, et al
   Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
   J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
7. BISWAS S, Shalimar
   Mycophenolate Mofetil in Autoimmune Hepatitis: Are We Ready for Primetime?
   J Hepatol. 2024 Mar 20:S0168-8278(24)00201-0. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   

   
   J Infect Dis

8. WHITTAKER R, Midtbo JE, Klovstad H
   Monitoring progress towards the elimination of hepatitis C as a public health threat in Norway: a modelling study among people who inject drugs and immigrants.
   J Infect Dis. 2024 Mar 27:jiae147. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. ZHANG H, Li M, Liu H, Dong Y, et al
   Juveniles, young adults, and infants with hepatitis B virus infection: A genomic study.
   J Med Virol. 2024;96:e29530.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

10. GUPTA N, Swindells S, Scarsi KK, Furl R, et al
    Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakers.
    J Viral Hepat. 2024 Mar 28. doi: 10.1111/jvh.13921.
    PubMed         Abstract available
    
    

    
    J Virol

11. SHENG Y, Deng Y, Li X, Ji P, et al
    Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release.
    J Virol. 2024 Mar 29:e0164923. doi: 10.1128/jvi.01649.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. KITAGAWA K, Kim KS, Iwamoto M, Hayashi S, et al
    Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers.
    PLoS Comput Biol. 2024;20:e1011238.
    PubMed         Abstract available
    
    

    
    PLoS One

13. VECHI HT, Bay MB, Freitas CHS, Sant'anna JGFC, et al
    Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study.
    PLoS One. 2024;19:e0301397.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.